Birdwatch Note
2024-09-23 23:49:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
第一三共が販売する「不活化・インフルエンザHAワクチン」は販売を終了しますが、これは第一三共が「経鼻インフルエンザワクチン フルミスト」の生産・販売に移行するためです。 なお、経鼻インフルエンザワクチン フルミストは生ワクチンであり、mRNAワクチンではありません。 フルミスト https://www.medicalcommunity.jp/products/druginfo/flumist_intranasal_spray
Written by 185125541AD8CA2A70B1793C6C01FBB092D66E6E3CE016A395E3FAB1591F3B3B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1837153685291606022
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1838365028770288100
- noteId - 1838365028770288100
- participantId -
- noteAuthorParticipantId - 185125541AD8CA2A70B1793C6C01FBB092D66E6E3CE016A395E3FAB1591F3B3B Participant Details
- createdAtMillis - 1727135352686
- tweetId - 1837153685291606022
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 第一三共が販売する「不活化・インフルエンザHAワクチン」は販売を終了しますが、これは第一三共が「経鼻インフルエンザワクチン フルミスト」の生産・販売に移行するためです。 なお、経鼻インフルエンザワクチン フルミストは生ワクチンであり、mRNAワクチンではありません。 フルミスト https://www.medicalcommunity.jp/products/druginfo/flumist_intranasal_spray
Note Ratings
| rated at | rated by | |
| 2024-09-30 11:55:05 -0500 | Rating Details | |
| 2024-09-28 04:02:07 -0500 | Rating Details | |
| 2024-09-27 17:17:27 -0500 | Rating Details | |
| 2024-09-27 17:07:30 -0500 | Rating Details | |
| 2024-09-27 11:09:59 -0500 | Rating Details | |
| 2024-09-27 06:37:07 -0500 | Rating Details | |
| 2024-09-27 05:50:27 -0500 | Rating Details | |
| 2024-09-27 05:11:03 -0500 | Rating Details | |
| 2024-09-27 05:08:49 -0500 | Rating Details | |
| 2024-09-27 04:59:22 -0500 | Rating Details | |
| 2024-09-27 03:55:24 -0500 | Rating Details | |
| 2024-09-27 03:49:32 -0500 | Rating Details | |
| 2024-09-27 03:49:28 -0500 | Rating Details | |
| 2024-09-27 03:46:53 -0500 | Rating Details | |
| 2024-09-27 03:43:27 -0500 | Rating Details | |
| 2024-09-27 03:42:31 -0500 | Rating Details | |
| 2024-09-27 03:41:11 -0500 | Rating Details | |
| 2024-09-27 03:39:50 -0500 | Rating Details | |
| 2024-09-27 03:37:24 -0500 | Rating Details | |
| 2024-09-27 03:35:20 -0500 | Rating Details | |
| 2024-09-27 03:35:01 -0500 | Rating Details | |
| 2024-09-27 03:34:19 -0500 | Rating Details | |
| 2024-09-27 03:33:36 -0500 | Rating Details | |
| 2024-09-27 03:32:54 -0500 | Rating Details | |
| 2024-09-27 03:32:45 -0500 | Rating Details | |
| 2024-09-27 03:32:40 -0500 | Rating Details | |
| 2024-09-27 03:32:18 -0500 | Rating Details | |
| 2024-09-27 03:32:09 -0500 | Rating Details | |
| 2024-09-25 17:54:52 -0500 | Rating Details | |
| 2024-09-25 10:58:41 -0500 | Rating Details | |
| 2024-09-24 03:37:57 -0500 | Rating Details | |
| 2024-09-23 20:20:05 -0500 | Rating Details | |
| 2024-09-23 19:43:28 -0500 | Rating Details | |
| 2024-09-23 18:54:53 -0500 | Rating Details | |
| 2024-09-23 18:53:59 -0500 | Rating Details | |
| 2024-09-23 18:52:33 -0500 | Rating Details | |
| 2024-09-30 06:21:24 -0500 | Rating Details | |
| 2024-09-27 03:33:30 -0500 | Rating Details |